DCTH logo

Delcath Systems (DCTH) Company Overview

Profile

Full Name:

Delcath Systems, Inc.

Sector:

Healthcare

Country:

United States

IPO:

May 3, 2018

Indexes:

Not included

Description:

Delcath Systems, Inc. focuses on developing innovative treatments for cancer. The company specializes in a unique delivery system that targets chemotherapy directly to tumors, minimizing side effects. Their main product is the Hepatic Delivery System, designed for liver cancer treatment, improving patient outcomes and quality of life.

Key Details

Price

$14.64

Annual Revenue

$2.06 M(-24.05% YoY)

Annual EPS

-$2.94(+28.64% YoY)

Annual ROE

-961.44%

Beta

1.32

Events Calendar

Earnings

Next earnings date:

Mar 6, 2025

Recent quarterly earnings:

Nov 8, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 24, 2019

Analyst ratings

Recent major analysts updates

Jan 17, 25 Craig-Hallum
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Aug 6, 24 Stephens & Co.
Overweight
Aug 6, 24 HC Wainwright & Co.
Buy
Jun 28, 24 Craig-Hallum
Buy
May 15, 24 HC Wainwright & Co.
Buy
May 14, 24 Stephens & Co.
Overweight
Mar 27, 24 HC Wainwright & Co.
Buy
Sep 7, 23 Canaccord Genuity
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Delcath Systems?
  • Does Delcath Systems pay dividends?
  • What sector is Delcath Systems in?
  • What industry is Delcath Systems in?
  • What country is Delcath Systems based in?
  • When did Delcath Systems go public?
  • Is Delcath Systems in the S&P 500?
  • Is Delcath Systems in the NASDAQ 100?
  • Is Delcath Systems in the Dow Jones?
  • When was Delcath Systems's last earnings report?
  • When does Delcath Systems report earnings?
  • Should I buy Delcath Systems stock now?

What is the ticker symbol for Delcath Systems?

The ticker symbol for Delcath Systems is NASDAQ:DCTH

Does Delcath Systems pay dividends?

No, Delcath Systems does not pay dividends

What sector is Delcath Systems in?

Delcath Systems is in the Healthcare sector

What industry is Delcath Systems in?

Delcath Systems is in the Medical Devices industry

What country is Delcath Systems based in?

Delcath Systems is headquartered in United States

When did Delcath Systems go public?

Delcath Systems's initial public offering (IPO) was on May 3, 2018

Is Delcath Systems in the S&P 500?

No, Delcath Systems is not included in the S&P 500 index

Is Delcath Systems in the NASDAQ 100?

No, Delcath Systems is not included in the NASDAQ 100 index

Is Delcath Systems in the Dow Jones?

No, Delcath Systems is not included in the Dow Jones index

When was Delcath Systems's last earnings report?

Delcath Systems's most recent earnings report was on Nov 8, 2024

When does Delcath Systems report earnings?

The next expected earnings date for Delcath Systems is Mar 6, 2025

Should I buy Delcath Systems stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions